SMA has undergone a remarkable transformation over the past decade, with advances in disease-modifying therapies fundamentally improving muscle strength, patient mobility, and quality of life in persons living with this condition. However, many patients continue to face disease-related challenges that need to be recognized.
SMA Awareness Month is an opportunity to recognize the importance of continued research, multidisciplinary care, patient advocacy, and education within the rare disease community.
At CheckRare, we are committed to raising awareness of rare disorders like SMA and helping connect healthcare professionals and patients with timely educational resources, expert insights, and emerging clinical developments.
For insights on SMA from the Muscular Dystrophy Association (MDA) 2026 Clinical & Scientific Conference, visit https://checkrare.com/sma-in-focus-practical-insights-from-mda-2026/
To learn more about the development of Itvisma gene therapy for SMA, visit https://checkrare.com/itvisma-gene-therapy-for-patients-with-spinal-muscular-atrophy/
To learn about the changing definition of success in the care and management of SMA, visit https://checkrare.com/spinal-muscular-atrophy-the-changing-definition-of-success/